Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Liver metastasis is the commonest form of distant metastasis in colorectal cancer. Selection
criteria for surgery and liver-directed therapies have recently been extended. However …

(1) Background: Colorectal cancer (CRC) is the third most common cancer and the second
leading cause of cancer-related mortality worldwide. Up to 50% of patients with CRC …

Background: Despite the recent worldwide dissemination of laparoscopic liver surgery, no
high-level evidence supports the oncologic safety of this approach. Objective: To evaluate …

Objective The relative benefit of anatomic resection (AR) versus non-anatomic resection
(NAR) of HCC remains poorly defined. We sought to evaluate the available evidence on …

Background The objective of the current study was to investigate both short-and long-term
outcomes of patients undergoing curative-intent resection for intrahepatic …

Aims To assess the safety and efficacy of parenchymal‐sparing hepatectomy (PSH) as a
treatment of colorectal liver metastases (CLM). Methods A comprehensive medical literature …

Simple Summary Liver resection for colorectal liver metastases (CRLM) represents the best
curative option; however, few patients are candidates for surgery. Microwave ablation …

Intrahepatic cholangiocarcinoma (ICC) is a rare, aggressive cancer of the biliary tract. It often
presents with locally advanced or metastatic disease, but for patients with early-stage …